Investing in mRNA Technologies
David Maza, Managing Director and Head of Product at Direxion, joins Cheddar News to discuss the evolution of mRNA technologies, future applications of this tech including fighting Lyme disease and HIV, and what this all means for investors.
More Videos
The Great Income Shift: How Americans Are Building Wealth Beyond Their Day Jobs
Christine Kahm, Head of Customer Strategy & Intelligence at Block, shares insights into how Americans are building income beyond the 9-to-5.
The Colonel Gets a Glow-Up: Inside KFC's Massive Global Rebrand
KFC Chief Concept Officer Christophe Poirier joins us to discuss the brand's sweeping global rebrand, menu innovation, and vision for the future.
SpaceX IPO Shocks Wall Street: Is This the Biggest Investment of the Decade?
Keith Snyder, Senior Equity Analyst at CFRA, explains what's driving investor demand for SpaceX and whether the excitement is justified.
SpaceX Takes Center Stage as Wall Street Eyes the Next Big Market Catalyst
Phil Rosen, Chief Market Strategist at ProCap Financial, discusses the growing anticipation around a SpaceX IPO and Oracle's AI-driven growth.
The Race to Build America’s Drone Delivery Network Is Officially Underway
Matternet CEO Andreas Raptopoulos discusses the future of drone delivery, U.S. manufacturing, FAA regulations and industry competition.
How the World Cup Became the Biggest AI Sports Event In History
The 2026 FIFA World Cup is deploying the largest live AI system ever used in professional sports. We go inside the tech with the man running it.
